World Conference on Interventional Radiology (WCIO) and Best of ASCO 2008
June 22 - 25, 2008  |  Hyatt Regency Century Plaza  |  Los Angeles, CA
 
Home
Program
      • CME Information
      • WCIO Posters
Registration
Housing
LA Tours & Attractions
Exhibitors & Sponsors
Committees
Contact Us
Archives
      • Washington DC
      • Italy
      • London
 
Search WCIO

 
Program
WCIO2007 Annual Meeting
May 14–17 2007
Washington Hilton, Washington, DC


SUNDAY, MAY 13, 2007

8:00 am – 6:00 pm   Registration
 

MONDAY, MAY 14, 2007

7:00 am - 8:00 am   Continental Breakfast

WCIO ANNUAL MEETING

7:45 am - 8:00 am   Welcome Address
8:00 am - 10:00 am   General Session I: COLORECTAL LIVER METASTASES
Moderator: Michael Choti
 
  1. Clinical Overview & Medical Management – Jordan Berlin
  2. Traditional Surgical Management – J. Nicholas Vauthey
  3. Evolving Surgical Therapies – Michael Choti
  4. Percutaneous Ablative Therapies – Luigi Solbiati
  5. TACE - Daniel Brown
  6. Radioembolization – Riad Salem
  7. Portal Vein Embolization– David Madoff
    View Presentation Slides (16.9mb)
  8. Concurrent/Combination Therapies - Michael Soulen
10:00 am - 10:30 am   Coffee Break – (Exhibit Hall)
10:30 am - 12:00 pm   General Session II: OTHER LIVER METASTASES
Moderator: Yuman Fong
 
  1. Neuroendocrine Tumors: Overview & Clinical Management - Richard R. P. Warner
  2. Neuroendocrine Tumors: Percutaneous Ablative & Transarterial Therapies -Thierry de Baere
    View Presentation Slides (15.3mb)
  3. Neuroendocrine Tumors: Cytoreductive Surgery – Yuman Fong
  4. Image Guided Interventional Therapies for Melanoma & Other Liver Metastases – Kevin Sullivan
    View Presentation Slides (17mb)
12:00 pm - 1:00 pm   Lunch Break & Poster Viewing (Exhibit Hall & Poster Room)
1:00 pm - 3:00 pm   WCIO/STM Joint Concurrent Session I: WORKING TOWARDS THE NEXT GENERATION OF THERAPEUTIC DEVICES AND TECHNIQUES
Moderators:Philippe L. Pereira
William Nau
 
  1. Advancing Thermal Therapy Technology & Delivery: Where We Are and Where We Should Be Heading – Thomas Ryan
  2. New Techniques & Strategies for High-Intensity Focused Ultrasound Thermal Therapy – Nathan McDannold
  3. New/Novel Microwave & RF Ablation – Damian Dupuy
    View Presentation Slides (33.8mb)
  4. Percutaneous & Catheter- Based High-Intensity Ultrasound for Conformal Thermal Therapy – Chris Diederich
  5. MR-Guided Laser Induced Thermal Ablative Therapy – Jason Stafford
1:00 pm - 3:15 pm   Practical Issues in IO Session I: PERCUTANEOUS ABLATIVE TECHNIQUES:
  TOOLS & SPECIFIC APPLICATIONS
TOOLS, TECHNIQUES & SPECIFIC ISSUES
Moderator: Jonathan Susman
  1. Angiodynamics Medical Ablative Systems - Allan Siperstein
    View Presentation Slides (11mb)
  2. Radiotherapeutics BSC– Jonathan Susman
    View Presentation Slides (12.1mb)
  3. Radionics Ablative Systems (RFA) – S. Nahum Goldberg
  4. Microwave Ablation – Stephen Kee
    View Presentation Slides (6.7mb)
  5. HIFU – David Gianfelice
  6. Cryoablation – Peter Littrup
  7. Laser Interstitial Therapy – Thomas Vogl
  8. Stereotatic Radiation – Joseph Herman
    View Presentation Slides (8.5mb)
GENERAL APPLICATIONS
Moderator: Michael Soulen
  1. Patient Selection & Triage Among Therapeutic Options - Michael Soulen
  2. Image Guidance: Monitoring & Endpoint Determination – Brad Wood
  3. Follow-up Imaging & Patient Care – Stephen Solomon
  4. Complications: Avoidance & Management - Thierry de Baere
    View Presentation Slides (12.6mb)
3:00 pm - 3:45 pm   Refreshment Break (Exhibit Hall)
3:30 pm - 5:30 pm   WCIO/STM Joint Concurrent Session II: ADVANCED IMAGING FOR MONITORING, CONTROL & ASSESSMENT
Moderators:Lawrence Schwartz
Nathan McDannold
 
  1. MRI-based Temperature Mapping for Monitoring Thermal Ablation – Andrew Webb
  2. Ultrasound Imaging Methods for Interventional Procedures – Flemming Forsberg
  3. Closed Loop Feedback Control of Thermal Ablation Using MRI-Based Thermotherapy” - Chrit Moonen
  4. Advanced Molecular Imaging in Image Guided Intervention – Heiko Schoder
  5. MRI-based Feedback Control of Prostate Thermal Ablation with Transurethral Ultrasound Applicator – Rajiv Chopra
  6. Molecular Imaging of Cancer in the Post-Genomic Era – Michael Kuo
3:45 pm - 5:30 pm   Practical Issues in IO Session II: TUMOR BOARD & CASE DISCUSSION
Moderators & Case Presenters:Colorectal Metastasis – Riad Salem
Neuroendocrine Tumor – Yuman Fong
Melanoma Metastasis – Thierry de Baere


Panelists:Jordan Berlin
Damian Dupuy
Nancy Kemeny
Allan Siperstein
6:00 pm - 7:30 pm   Welcome Reception
7:30 pm - 9:00 pm   Topic Related Symposium - Colorectal Carcinoma – (Invited Drug Companies Only)
Chair: Wells Messersmith
7:30 pm - 9:00 pm   Topic Related Symposium - Exploring Multi-Disciplinary Advances in Colorectal Cancer Treatment
Presented by Sanofi-aventis
7:30 pm - 9:00 pm   Industry Symposium - How to Get Your RFA Business Cooking
Made possible by a grant from Valleylab
 

TUESDAY, MAY 15, 2007

7:00 am - 5:30 pm   Registration
7:00 am - 8:00 am   Continental Breakfast
(Exhibit Hall)
8:00 am - 10:00 am   General Session III: PRIMARY LUNG CANCER
Moderator: Damian Dupuy
 
  1. Clinical Overview – Gerald Abbott
  2. Medical Management – Thomas Lynch
    View Presentation Slides (4.8mb)
  3. Standard & Evolving Surgical Therapies – Hiran C. Fernando
  4. Radiation Therapy for NSCLC – Brian Kavanagh
  5. Ablation Part 1: RFA & Microwave – Damian Dupuy
  6. Ablation Part 2: Cryoablation – Peter Littrup
  7. Panel Discussion
10:00 am – 10:30 am   Coffee Break
(Exhibit Hall)
10:30 am - 11:30 am   General Session IV: LUNG METASTASES
Moderator: Thomas DiPetrillo
 
  1. Clinical Overview & Medical Management – Thomas Lynch
    View Presentation Slides (1.4mb)
  2. Surgical Management – Harvey Pass
  3. Radiation Therapy – Thomas DiPetrillo
  4. Image Guided Interventional Ablation Therapies – Stephen Solomon
11:30 am - 12:00 pm   Keynote Speaker
John Niederhuber, MD – National Cancer Institute
Frontiers of Cancer Biology
View Presentation Slides (21mb)
12:00 pm - 1:30 pm   Lunch Break & Poster Viewing
(Exhibit Hall)
1:00 pm - 3:00 pm   WCIO/STM Joint Concurrent Session III: BIOLOGICAL BASIS OF PERCUTANEOUS AND TRANSARTERIAL ONCOLOGY THERAPIES
Moderators:S. Nahum Goldberg
Peter M. Corry
 
  1. Biology of Hyperthermia – Peter M. Corry
    View Presentation Slides (13.3mb)
  2. Thermal Ablation Biology – S. Nahum Goldberg
    View Presentation Slides (18.4mb)
  3. Biological Aspects of Transarterial Therapy – Jeff Geschwind
  4. The Role of Immunology in Hyperthermic Therapy of Cancer – Elizabeth Repasky
  5. Combined Modality Therapy – Mark W. Dewhirst
1:00 pm - 3:15 pm   Practical Issues in IO Session III: LUNG CANCER AND EXTRAHEPATIC METASTASES
Moderator: Damian Dupuy & Matthew Callstrom
 
  1. Patient Selection & Triage Among Therapies – Jo-Anne Shepard
    View Presentation Slides (5.8mb)
  2. Image Guidance, Monitoring Endpoint Determination & Technical Tricks (Lungs) – Riccardo Lencioni
    View Presentation Slides (13.6mb)
  3. Follow-up Imaging & Patient Management – Robert Suh
    View Presentation Slides (16mb)
  4. Complications: Avoidance & Management - Kamran Ahrar
    View Presentation Slides (59mb)
  5. Adrenal Ablation – William Mayo-Smith
  6. Palliation with Image –Guided Techniques – Matthew Callstrom
    View Presentation Slides (39.4mb)
3:00 pm - 3:45 pm   Refreshment Break
(Exhibit Hall)
3:30 pm - 5:30 pm   WCIO/STM Joint Concurrent Session IV: COMBINING SYSTEMIC, REGIONAL & LOCAL THERAPIES FOR IMPROVED CLINICAL OUTCOME
Moderators:Yuman Fong
Mark Hurwitz
 
  1. Combined Chemo – Embolization/Ablation – Riccardo Lencioni
    View Presentation Slides (17.1mb)
  2. Combined Resection/Ablation – Ronnie Poon
    View Presentation Slides (26.4mb)
  3. Combined Liposomal Chemo/Ablation and/or Hyperthermia – Brad Wood
  4. Combined XRT/Hormonal Therapy/Hyperthermia or Ablation – Mark Hurwitz
  5. Combined RFA & Regional Chemotherapy – Nancy E. Kemeny
3:45 pm - 5:30 pm   Practical Issues in IO Session IV: TUMOR BOARD & CASE DISCUSSIONS
Moderators:Damian Dupuy & Thomas DiPetrillo
 
PANELISTS:Riccardo Lencioni
William Mayo-Smith
Jo-Anne Shepard
Robert Suh
 
CASES:Primary Lung Cancer
Lung Metastasis
Adrenal Metastasis
6:00 pm - 9:00 pm   Industry Symposium
Evidence-Based Medicine in the Medical Device World: Where Are We and Where do We Need to Go?
Made Possible by a grant from Boston Scientific Corporation
 

WEDNESDAY, MAY 16, 2007

7:00 am - 5:00 pm   Registration
7:00 am - 8:00 am   Continental Breakfast
8:00 am - 10:00 am   General Session V: HCC
Moderator: Riccardo Lencioni
 
  1. Clinical Overview & Medical Management – Paul Thuluvath
  2. Traditional & Evolving Surgical Therapies – Ronnie Poon
  3. Transplant Surgery – Myron Schwartz
  4. Chemical Ablation Therapies – Michael Soulen
  5. Thermal Ablation Therapies – Riccardo Lencioni
  6. Role of Radiation Therapy in the Management of Liver Cancer – Ross Abrams
  7. Transcatheter Intra-arterial Therapies: Bland Embolization– Daniel Brown
  8. Transcatheter Intra-arterial Therapies: TACE – Jeff Geschwind
  9. Transcatheter Intra-arterial Therapies: Radioembolization – William Rilling
  10. Combination Therapies – Jae-Hyung Park
  11. Role of Therapeutic Approaches as Bridge to Transplantation – David Lu
  12. Imaging Post Regional Therapy – Ihab Kamel
10:00 am - 10:30 am   Coffee Break
(Exhibit Hall)
10:30 am - 12:00 pm   General Session VI: INTERNATIONAL PERSPECTIVES ON MANAGEMENT OF HCC
Moderator: Jeff Geschwind

Countries:
   Brazil -Valeria Cardoso de Souza
   China – TBD
   Hong Kong – Ronnie Poon
   Italy – Riccardo Lencioni
   Japan – Keigo Osuga
   Korea – Jin-Wook Chung
   South Africa – Coert de Vries
   United Kingdom –Timothy Meyer
12:00 pm - 1:30 pm   Lunch Break & Poster Viewing
(Exhibit Hall)
1:30 pm - 3:00 pm   Concurrent Session I: SELECTED ABSTRACTS
Moderator: S. Nahum Goldberg
  1 Combined Chemoembolization and Percutaneous Radiofrequency Ablation for Local Control of Liver Tumors
M. C. Higgins1, J. I. Mondschein1, S. W. Stavropolous1, C. M. Tuite1, T. W. Clark2, M. C. Soulen1;
1University of Pennsylvania, Philadelphia, PA, 2New York Universtiy, New York, NY.

2 Algorithm Optimization For Multitined Radiofrequency Ablation: A Comparative Study In Ex Vivo Bovine Livers
L. Appelbaum1, J. Sosna1, I. Nissenbaum1, E. Libson1, S. N. Goldberg2;
1Hadassah Hebrew University Medical Center, Jerusalem, ISRAEL, 2Beth Israel Deaconess Medical Center, Boston, MA.
View Presentation Slides (8.1mb)

3 Radiofrequency Ablation with HDR Brachytherapy in the Treatment of Stage I Non-Small Cell Lung Cancer
M. Chan, D. Dupuy, T. Ng, W. Mayo-Smith, G. Cardarelli, T. DiPetrillo;
Rhode Island Hospital, Providence, RI.
View Presentation Slides (2.7mb)

4 Ethanol Ablation of Hepatocellular Carcinoma Sized up to 5 cm by Using A Multi-pronged Injection Needle with Single Treatment Session
M. Kuang1, M. Lu1, Z. Xu2, X. Xie2, H. Xu2, G. Liu2;
1Department of Hepatobiliary Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, CHINA, 2Department of Medical Ultrasonics, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, CHINA.
View Presentation Slides (16.9mb)

5 Management of Painful Acetabular Metastases by Combined Radiofrequency Ablation and Cementoplasty
A. V. KULKARNI, S. S. KULKARNI;
TATA MEMORIAL HOSPITAL, MUMBAI, INDIA.

6 Effect of radiofrequency ablation on the immune system in cancer patients
C. Gouttefangeas1, S. P. Haen1, M. Widenmeyer1, Y. Shebzukhov2, S. Clasen1, D. Schmidt1, A. Stenzl1, P. L. Pereira1, H. Rammensee1;
1Eberhard-Karls-University, Tuebingen, GERMANY, 2German Rheumatology Research Centre, Berlin, GERMANY.

7 Radiofrequency Ablation (RFA) of Breast Cancer Lumpectomy Cavities: Tissue-Based Validation of a Technique Intended to Increase Negative Margins After Breast Conservation Surgery.
J. Eckman1, H. Kwan2, S. Orrω3, M. Rais3, M. Spinelli4, K. Christy2, C. Germain1, D. Castrodale1, J. Coad1;
1West Virginia University, Morgantown, WV, 2RITA Medical, Inc., Fremont, CA, 3Azienda Sanitaria Locale, Cagliari, ITALY, 4Salvin Corona di Gardagnate, Milan, ITALY.

8 Comparison of Percutaneous and Laparoscopic Renal Cryoablation
J. L. Hinshaw, A. Shadid, S. Hedican, S. Nakada, T. Moon, F. T. Lee, Jr;
University of Wisconsin School of Medicine and Public Health, Madison, WI.
View Presentation Slides (4.8mb)

9 Percutaneous Lung RFA: a Single-center Experience with a Follow up longer than 4 years
A. Catino, V. Mattioli, V. Fazio, G. Ranieri, G. Vinciarelli, G. Laricchia, C. Gadaleta;
Oncology Institute, Bari, ITALY.
View Presentation Slides (26.2mb)

1:30pm – 3:15 pm   Concurrent Session II: TRANSCATHETER INTRA-ARTERIAL THERAPIES:
TECHNICAL CONSIDERATION & ISSUES Moderator: William Rilling
  GENERAL TECHNICAL CONSIDERATIONS:
  1. Technique of TACE - Lynn Brody
  2. Non-target Embolization: How to Avoid It – Jin-Wook Chung
  3. TACE in High Risk Patients – Daniel Brown
  4. Complications of TACE – William Rilling
  5. Radioembolization: Dose Calculation – Daniel Sze
  6. Radioembolization Therapy: Anatomical Considerations – Riad Salem
  7. Use of 3D Imaging in Vascular Intervention of Cancer – Marshall Hicks
ISSUES – PANEL DISCUSSION
Panelist: Lynn Brody
Daniel Brown
Jin-Wook Chung
Jeff Geschwind
Marshall Hicks
William Rilling
Riad Salem
Daniel Sze
  1. Patient Selection & Triage Among Therapeutic Options
  2. Complications: Avoidance & Management
  3. Follow-up Imaging & Patient Management
3:00 pm - 3:45 pm   Refreshment Break
(Exhibit Hall)
3:30 pm – 5:00 pm   Concurrent Session III: SELECTED ABSTRACTS
Moderator: S. Nahum Goldberg
10 Evaluations of Pulsed High Intensity Focused Ultrasound Exposures for enhancing the Synergistic Effects of TNFα and Bortezomib in a Murine Squamous Cell Carcinoma
Sapna Shah, Jason Poff, Bryan Traugher, Clint Allen, Arick Colunga, Zhong Chen, Mamesia Kabia, Jianwu Xie, Alfia Khaibullina, Bradford J Wood, Carter VanWaes, Victor Frenkel;
Diagnostic Radiology Department, Clinical Center, National Institutes of Health, Bethesda, MD, Head and Neck Surgery Branch, National Institutes on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD.

11 Percutaneous arm port device placement in 1200 cancer patients : Results of a French multicenter- Anticancer Research Institute
P. Marcy1, N. Amoretti1, O. Hericord1, P. Bondiau1, F. Peyrade1, J. Gallard2, F. Bredin3, O. Dassonville1;
1Antoine Lacassagne Anticancer Research Institute, Nice, FRANCE, 2Franηois Baclesse Anticancer Research Institute, Caen, FRANCE, 3Franηois Baclesse Anticancer Research Institute, Caen, FRANCE.
View Presentation Slides (2.5mb)

12 Angiographic and CT Anatomy of the Wistar Rat: A potential model for basic research on Intra-arterial Therapies
G. McLennan, S. Ju, S. L. Bennett, N. S. K. Hekmatyar, Y. Liang;
Indiana University, Indianapolis, IN.

13 Effectiveness of Conformal External Radiation Therapy Combinated with Intervantional Radiology for Hepatocellular Carcinoma with Portal Tumor Thrombi.
M. Sato, S. Shirai, K. Kishi, H. Tanihata, N. Kawai;
Wakayama Medical University, Wakayama, JAPAN.
View Presentation Slides (1.2mb)

14 TACE with HepaSphere microspheres loaded with chemotherapeutic agent: early experience in Italy of a multi-centre study.
C. Massa Saluzzo1, M. Grosso2, C. Vignali3, A. Nicolini4, P. Quaretti1, G. Gallarato2, P. Petruzzi3, S. Crespi4, A. Azzaretti1, F. Melchiorre2, I. Sarti3, L. Martinetti4;
1IRCCS Policlinico San Matteo, Pavia, ITALY, 2ASO Santa Croce e Carle, Cuneo, ITALY, 3Azienda Ospedaliera Pisana P.O. Cisanello, Pisa, ITALY, 4Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, ITALY.

15 Comparison of Coagulated Volume using 915MHz and 2450MHz Microwave in Vitro Pig livers
P. Liang, Y. Sun, Z. Cheng, Y. Wang, Q. Shao, H. Liang, W. Shi, B. Dong;
Department of Ultrasound, PLA general hospital, Bejing, CHINA.
View Presentation Slides (11.7mb)

16 Standardization of Imaging Protocols, Acquisition, and Interpretation for Tumor Response Assessment in Clinical Trials to Evaluate Image Guided Interventions
W. L. Monsky1, J. Boone1, R. Badawi1, M. Buonocore1, J. McGahan1, N. Raghunand2, R. Gottlieb3, W. Jacqmein4, G. S. Dorfman5;
1University of California, Davis, Sacramento, CA, 2University of Arizona, Tucson, AZ, 3RoswellPark, Buffalo, NY, 4Boston Scientific Corp., Natick, MA, 5National Cancer Institute, Rockville, MD.
View Presentation Slides (3.5mb)

17 Role of Contrast Enhanced Ultrasound in Assessing therapeutic response of liver malignancies after microwave ablation - evaluating tumor residue and local recurrent
X. Yu, P. Liang, B. Dong, H. Li, L. Liu, J. Fan, M. Li, D. Yu, Yang Wang, X Cao;
PLA General Hospital, Beijing, CHINA

18 Analysis of Clinical Toxicity in Patients Undergoing Percutaneous Intra-Arterial Hepatic Perfusion (PHP) with Melphalan for Unresectable Hepatic Malignancies
J. F. Pingpank1, R. E. Royal1, H. R. Alexander2, M. K. Horne3, B. J. Wood4, Z. Neeman4, A. W. Kam4, S. K. Libutti1, M. S. Hughes1, U. S. Kammula1, T. Beresneva1, S. E. Ohl1;
1Surgery Branch, NCI, Bethesda, MD, 2Division of Surgical Oncology, Dept of Surgery, Baltimore, MD, 3Department of Laboratory Medicine, NIH, Bethesda, MD, 4Diagnostic Radiology Division, CCR, NIH, Bethesda, MD.
View Presentation Slides (11.3mb)

3:45 pm – 5:00 pm   Concurrent Session IV: TUMOR BOARD & CASE DISCUSSIONS ON HCC
Moderator:Ronnie Poon
 
CASES:Small HCC Nodule
Intermediate
Advanced
 
Panelist:Ronnie Poon
Riad Salem
Myron Schwartz
Daniel Sze
Paul Thuluvath
6:00 pm - 9:00 pm   Industry Symposia

RFA and Embolization for the Management of Soft Tissue Malignancies; Liver and Breast
Made possible by a grant from Angiodynamics
 

THURSDAY, MAY 17, 2007

7:00 am - 5:00 pm   Registration
7:00 am - 8:00 am   Continental Breakfast
8:00 am - 10:00 am   General Session VII: GENITOURINARY – RENAL CANCER
Moderator: Debra Gervais
 
  1. Clinical Overview – Timothy Clark
    View Presentation Slides (1.7mb)
  2. Medical Management - Roberto Pili
    View Presentation Slides (3.2mb)
  3. Traditional & Evolving Surgical Therapies – Peter Pinto
    View Presentation Slides (25.2mb)
  4. Percutaneous Ablative Therapies: RFA - Ron Zagoria
  5. Percutaneous Ablative Therapies: Cryoablation – Stuart Silverman
10:00 am - 10:30 am   Coffee Break
(Exhibit Hall)
10:30 am - 11:30 am   General Session VIII: GENITOURINARY – RENAL CANCER (CONT.)
Moderator: Stephen Solomon
 
  1. Transcatheter Arterial Therapy – Kamran Ahrar
    View Presentation Slides (90mb)
  2. Patient Selection & Triage Among Therapeutic Options – J. William Charboneau
    View Presentation Slides (9.9mb)
  3. Imaging Follow-up & Patient Management – Debra Gervais
  4. Panel Discussion
11:30 am – 12:00 pm   Keynote Speaker:
Daniel C. Sullivan, MD – National Cancer Institute
Improving Cancer Management with Image-guided Interventions
View Presentation Slides (11.7mb)
12:00 pm – 1:30 pm   Lunch And Poster Viewing
(Exhibit Hall)
1:30 pm - 3:00 pm   Concurrent Session V
1:30 pm - 2:15 pm   Breast Cancer
Moderator: Bruno Fornage
 
  1. Overview: Issues & Challenges in Image-Guided Ablation of Breast Cancer – Bruno D. Fornage
  2. Radio Frequency Ablation – V. Susan Klimberg
  3. Cryoablation – Peter Littrup
  4. High Intensity Focused Ultrasound – David Gianfelice
2:15 pm - 3:00 pm   Bone Cancer
Moderator: Matthew Callstrom
 
  1. Ablation and Stabilization of Vertebral Body Tumors – Afsin Gangi
  2. Coblation & Cementoplasty of Metastatic Bone Tumors – Wade Wong
    View Presentation Slides (48.6mb)
  3. Cryoablation of Metastatic Soft Tissue Masses – Peter Littrup
  4. Radiofrequency Ablation of Painful Bone Metastases – Damian Dupuy
    View Presentation Slides (1.9mb)
1:30 pm - 3:00 pm   Concurrent Session VI: RENAL CANCER
Moderators: Debra Gervais & Stephen Solomon
 
  1. Triage Among Nephron Sparing Options – Surgery vs. Percutaneous – What Does the Evidence Show? - Stephen Solomon
  2. Tumor Board – Debra Gervais, Peter Mueller, Stephen Solomon, Peter Pinto, William Charboneau, Stuart Silverman
  3. Complications & Management – Peter Mueller
3:00 pm - 3:30 pm   Refreshment Break (Exhibit Hall)
3:30 pm - 5:00 pm   Concurrent Session VII: PRELIMINARY REPORTS ON EMERGING APPLICATIONS AND EARLY TRIALS RESULTS
Moderator: Gary Dorfman
 
  1. Live Tumor Therapy: Surgical Approaches & Trials – Eren Berber
  2. Liver Tumor Therapy: Percutaneous Approaches & Trials – Riccardo Lencioni
    View Presentation Slides (21.7mb)
  3. Renal Tumor Therapy: Current Data & Trials – Debra Gervais
  4. Clinical Trials in Japan on HCC and CRC Mets – Yasuaki Arai
    View Presentation Slides (6mb)
  5. Lung Tumor Therapy: Percutaneous Approaches & Trials – Damian Dupuy
  6. Breast Tumor Therapy: RFA & Surgical Trials – V. Suzanne Klimberg
  7. Breast Tumor Therapy: HIFU – David Gianfelice
3:30 pm - 5:00 pm   Concurrent Session VIII: PRACTICE MANAGEMENT
Moderator: Riad Salem
 
  1. Role of Physician Extenders – Kelvin Hong & Tamara Wahlin
    View Presentation Slides (500k)
    View Presentation Slides (550k)
  2. Integration of Interventional Oncology Practice
  3. Financial Issues Panel Discussion
Panelist:Daniel Brown
Jeff Geschwind
William Rilling
Riad Salem
Catherine Tuite
5:00 pm   Adjourn

SELECTED POSTERS

    P1 Radiofrequency ablation of liver tumors: a novel needle perfusion technique enhances efficiency
P. Abitabile, C. A. Maurer;
Kantonsspital, Liestal, SWITZERLAND.

P2 TACE with microspheres preloaded with Doxorubicin in cholangiocarcinoma
C. Aliberti1, M. Tilli1, G. Benea1, R. Rizzati1, G. Fiorentini2;
1Delta Hospital Ferrara, Ferrara, ITALY, 2Department of Oncology,General Hospital San Giuseppe,, Empoli, ITALY.

P3 A Case of Hepatocellular Carcinoma Supplied by Left Internalthoracic Artery Treated with Transcatheter Arterial Chemoembolization - To Avoid Major Complications Such as Skin Necrosis
H. ANAI1, H. SAKAGUCHI2, H. UCHIDA1, K. KICHIKAWA2;
1SHITENNOJI HOSPITAL, Osaka, JAPAN, 2NARA MEDICAL UNIVERSITY, KASHIHARA, JAPAN.

P4 Percutaneous Cryoablation of 84 Renal Masses in 83 Patients
T. D. Atwell, M. A. Farrell, M. R. Callstrom, B. D. Lewis, I. Frank, W. Charboneau;
Mayo Clinic – Rochester, Rochester, MN.

P5 Unresected Breast Cancer: Evolution of Imaging Findings Following Cryoablation
J. T. Bergin, G. A. Sisney, E. S. Burnside, L. R. Salkowski;
University of Wisconsin Hospital and Clinics, Madison, WI.

P6 TACE plus RFA as SINGLE-STEP Treatment of Liver Malignancies
A. Catino, V. Mattioli, V. Fazio, G. Ranieri, G. Vinciarelli, G. Laricchia, C. Gadaleta;
Oncology Institute, Bari, ITALY.

P7 The role of ultrasound-guided percutaneous embolization of feeding vessel combined with radiofrequency ablation in treating hepatocellular carcinoma
MH. Chen, H. Zhang, W. Yang, YB. Hou, L. Huo, K. Yan, JY. Wu, L. Shen;
The School of Oncology, Peking University, Beijing, CHINA

P8 Radioembolisation (Ittrium 90) of liver mets.Two years experience
R. Cianni, E. Notarianni, A. Saltarelli, R. Salvatori, G. Di Stefano;
S.M.GORETTI HOSPITAL, LATINA, ITALY.

P9 CAM/Ethiodol/PVA Chemoembolization Of Liver Metastases From Esophageal Carcinoma
L. A. Dinardo1, M. C. Soulen1, A. Patel1, T. W. Clark2;
1University of Pennsylvania, Philadelphia, PA, 2New York Universtiy, New York, NY.

P10 Preliminary Experience with a Novel Electromagnetic Tracking System for CT-guided Ablation Procedures
D. E. Dupuy, E. Morrell, W. W. Mayo-Smith;
Rhode Island Hospital, Providence, RI.

P11 Sequential activation of multiple ground pads during radiofrequency ablation reduces skin heating - in vivo results in a porcine model
D. Haemmerich, D. J. Schutt, M. Swindle;
Medical University of South Carolina, Charleston, SC.

P12 Comparison of Radiofrequency and Microwave ablation: Insights from computer modeling
W. Schramm, D. Haemmerich;
Medical University of South Carolina, Charleston, SC.

P13 Combination Treatment of Hepatocellular Carcinoma Using TheraSphere and Trans-Arterial Chemoembolization
M. J. Hall, E. Hohenwalter, W. S. Rilling, R. A. Hieb, S. M. Tutton;
Medical College of Wisconsin, Milwaukee, WI.

P14 Extracorporeal High Intensity Focused Ultrasound for the Treatment of Renal Tumours
R. O. Illing1, T. A. Leslie1, J. E. Kennedy1, F. Wu2, G. R. ter Haar3, R. R. Phillips1, A. S. Protheroe1, D. W. Cranston1;
1Churchill Hospital, Oxford, UNITED KINGDOM, 2Chongqing University of Medical Sciences, Chongqing, CHINA, 3Royal Marsden Hospital, Sutton, UNITED KINGDOM.

P15 A 3D Ultrasound Navigation System for Microwave Coagulation Therapy of Liver Cancer
X. Jing1, L. Tong2, Z. Sen-qiang1, R. Hen2, W. Yang2, Y. Xiang-dong1, C. Ken1, L. Ping2;
1Tsinghua University, Beijing, CHINA, 2Department of Ultrasound, General Hospital of PLA, Beijing, CHINA.

P16 Multiple-electrode RF ablation: Wider electrode spacing does not necessarily mean larger ablation zone
P. F. Laeseke, V. Prasad, L. A. Sampson, F. T. Lee Jr, C. L. Brace;
University of Wisconsin, Madison, WI.

P17 Quadra-Fuse Percutaneous Ethanol Injection in the Treatment of Early-Stage Hepatocellular Carcinoma: A Pilot Clinical Trial
R. Lencioni, L. Crocetti, E. Bozzi, C. Della Pina, D. Cioni;
University of Pisa, Pisa, ITALY.

P18 Combined Radiofrequency Ablation And Doxorubicin Eluting Beads Arterial Embolization In Hepatocellular Carcinoma: A Pilot Clinical Trial
R. Lencioni, L. Crocetti, P. Petruzzi, E. Bozzi, A. Cicorelli, R. Cioni, C. Vignali;
University of Pisa, Pisa, ITALY.

P19 Safety and Efficacy of 90Y Radioembolization for Hepatocellular Carcinoma presenting with and without Portal Vein Thrombosis
R. Lewandowski1, L. Kulik1, B. Carr2, M. Mulcahy1, B. Atassi1, R. Ryu1, K. Sato1, M. Abecassis1, R. Omary1, R. Salem1;
1Northwestern Memorial Hospital, Chicago, IL, 2University of Pittsburgh Hospital, Pittsburgh, PA.

P20 Making rabbit model of VX2 liver tumor and studying the imaging
C. Li;
QiLu Hospital of Shandong University, PR China, Ji Nan, CHINA.

P21 The development of clinical application of microwave ablation in China
B. Dong, P. Liang, X. Yu, D. Yu, Y. Wang, D. Zhang;
Department of Ultrasound, PLA general hospital, Bejing, CHINA.

P22 Preliminary Study of Sonography-Guided Microwave Ablation of Renal and Adrenal Tumors
P. Liang, X. Yu, D. Zhang, Y. Wang, Q. Shao, B. Dong;
Department of Ultrasound, PLA general hospital, Bejing, CHINA.

P23 Percutaneous Cryotherapy of Lung Tumors: Ablation in High Risk Patients
P. J. Littrup1, H. D. Aoun2, S. S. Nakat2, B. A. Adam1;
1Karmanos Cancer Center, Detroit, MI, 2Wayne State University, Detroit, MI.

P24 Percutaneous Cryotherapy of Liver Tumors: Outcomes Appear Independent of Tumor Size & Location
P. J. Littrup1, H. D. Aoun2, S. S. Nakat2, B. A. Adam1;
1Karmanos Cancer Center, Detroit, MI, 2Wayne State University, Detroit, MI.

P25 A Robot System for US-Guided Microwave Ablation Therapy (A Pilot Study)
T. Lu1, J. Xu2, H. Ren1, Y. Wang1, P. Liang1, K. Chen2, X. Yang2;
1Chinese PLA General Hospital, Beijing, CHINA, 2Tsinghua University, Beijing, CHINA.

P26 RFTA of Small Breast Cancer: 3T MRI Monitoring of Effectiveness
G. Manenti, E. Cossu, O. Buonomo, F. Bolacchi, C. Pistolese, E. Bonanno, G. Simonetti;
POLICLINICO TOR VERGATA, ROME, ITALY.

P27 Transarterial hepatic chemoembolization (TACE) with Oxaliplatin-loaded microspheres (Hepasphere) and percutaneous radiofrequency thermal ablation (RFA) as a combined therapy for unresectable hepatic tumors.
G. Poggi1, P. Quaretti2, C. Minoia1, C. Massa Saluzzo2, A. Riccardi3, C. Teragni1, R. Gaggeri1, A. Delmonte1, A. Amatu1, S. Bernieri1, A. Ronchi1, C. Sottani1, G. Bernardo1;
1IRCCS FONDAZIONE MAUGERI, Pavia, ITALY, 2POLICLINICO SAN MATTEO, Pavia, ITALY, 3IRCCS FONDAZIONE MAUGERI UNIVERSITA' di PAVIA, Pavia, ITALY.

P28 N1-S1 Cell Proliferation Inhibition with Benzamide Riboside
G. McLennan, S. Ju, S. L. Bennett, J. N. Hiremagular;
Indiana University, Indianapolis, IN.

P29 Evaluation of Deformable Superabsorbent Polymer Microspheres for Treatment of Hypervascular Liver Tumours
C. McMahon, P. Beddy, M. Guiney, N. McEniff, M. Ryan;
St. James Hospital, Dublin, IRELAND.

P30 Cost-Effectiveness of Percutaneous Radiofrequency Ablation for Malignant Primary Renal Neoplasms
B. D. Midkiff, D. E. Dupuy, R. Y. Gohh, W. W. Mayo-Smith;
Rhode Island Hospital, Providence, RI.

P31 Transarterial Chemoinfusion in the treatment of liver tumors: A single center experience
G. Narayanan, D. Lamus, K. Barbery, J. Baeza, K. Vaheesan, L. Feun, J. Yrizarry;
University of Miami, Miami, FL.

P32 Management of Recurrent Pleural Effusions and Ascites with the Pleurx Catheter
G. Narayanan, K. Barbery, P. Dalvie, J. Yrizarry;
University of Miami, Miami, FL.

P33 Results of Chemoembolization for Unresectable Hepatocellular Carcinoma in Patients with and without Chronic Liver Disease
M. J. Neisen, M.D., W. S. Rilling, M.D., R. A. Hieb, M.D., E. J. Hohenwalter, M.D., S. M. Tutton, M.D., K. K. Christians, M.D., E. J. Quebbeman, M.D., PhD., J. Franco, M.D., K. Saeian, M.D.;
Froedtert and Medical College of Wisconsin, Milwaukee, WI.

P34 Clinically Significant Hepatic Artery Injury Following TACE: Fact or Fiction
R. O'Hara, W. Stavropoulos;
University of Pennsylvania, Philadelphia, PA.

P35 RF Ablation induces early DNA damage and prolonged apoptotic responses in peripheral tumor
S. Rahmanuddin, S. A. Solazzo, R. Schor-Bardach, S. N. Goldberg;
Beth Israel Deaconess Medical Center Harvard University, Boston, MA.

P36 Breathing influence on MR temperature monitoring applying the proton resonance frequency method in liver and kidney
H. Rempp, A. Boss, P. Martirosian, M. Kraiger, T. Herberts, S. Clasen, C. D. Claussen, P. L. Pereira, F. Schick;
University of Tόbingen, Tόbingen, GERMANY.

P37 Percutaneous Radiofrequency Ablation of Hepatocellular Adenoma: Initial Experience
E. Yoo, H. Rhim, Y. Kim, D. Choi, H. K. Lim;
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, REPUBLIC OF KOREA.

P38 Effect of artificial ascites on the thermal injury at the diaphragm and stomach in radiofrequency ablation of the liver: An experimental study in a porcine model
E. Lee, H. Rhim, Y. Kim, D. Choi, H. K. Lim;
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, REPUBLIC OF KOREA.

P39 FDG-PET as a Prognostic Tool in Evaluating Treatment Response of Thermal Ablation in Patients with Non Small Cell Lung Cancer
A. A. Scappaticci, D. C. Yoo, R. B. Noto, T. DiPetrillo, D. E. Dupuy;
Rhode Island Hospital Brown Medical School, Providence, RI.

P40 Percutaneous multipolar and multi-electrodes radiofrequency ablation for the treatment of large HCC: mid-term results
O. Seror, G. N'Kontchou, C. Barrucand, M. Assaban, J. Trinchet, M. Beaugrand, N. Sellier;
Hτpital Jean Verdier, AP-HP, Bondy, FRANCE.

P41 The Effects of Pulsed High-Intensity Focused Ultrasound Exposures on Metastasis
Jennifer Shih1, Claire Pollock2, Mary Angstadt1, Bryan Traughber1, Yide Mi1, Sapna Shah1, Victor Frenkel1, Bradford J. Wood1;
1Molecular Imaging Laboratory, Department of Diagnostic Radiology, Clinical Center; 2Cell and Cancer Biology Branch, National Cancer Institute; National Institutes of Health, Bethesda, MD.

P42 Collection, Evaluation and Analysis of Volumetric, Image-based 3D Data for Quality Assurance and Data Analysis in Multi-institutional Interventional Clinical Trials: Experience in Radiation Therapy Clinical Trials
W. L. Straube1, W. R. Bosch1, J. W. Matthews1, J. A. Purdy2;
1Washington University, St. Louis, MO, 2UC Davis, Sacramento, CA.

P43 The Quantitative Measurement of Iodine Concentration with Abdominal C-arm CT: Phantom Study
Y. Funama1, D. S. Graff2, J. H. Geschwind2, E. K. Fishman2, K. Taguchi2;
1Johns Hopkins University & Kumamoto University, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD.

P44 Improved Targeting of RF Ablation using Non-rigid Registration of Pre-procedural MRI with Intra-procedural Unenhanced CT
S. Tatli1, N. Archip1, P. Morrison1, S. K. Warfield2, F. A. Jolesz1, S. G. Silverman1;
1Brigham and Women's Hospital, Boston, MA, 2Children's Hospital, Boston, MA.

P45 Pleural insufflation to create safe windows of ablation for lesions at the edge of the lung
S. B. Solomon, R. H. Thornton, R. J. Downey;
Memorial Sloan Kettering Cancer Center, New York, NY.

P46 Phrenic nerve injury during lung ablation: anatomic considerations.
R. H. Thornton, S. B. Solomon, M. S. Bains;
Memorial Sloan Kettering Cancer Center, New York, NY.

P47 Diffusion Weighted MR Imaging in Locoregional Treatment of Liver Tumours
S. Venkatesh, F. P. Leung, S. Wang;
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, SINGAPORE.

P48 Internally-Cooled Antenna for Microwave Ablation: Results in Ex Vivo and In Vivo Porcine Liver Model
Y. Wang;
Department of Ultrasound, PLA general hospital, Beijing, CHINA.

P49 Percutaneous Radiofrequency Ablation Using a Multiple-Electrode Switching-Generator Radiofrequency Ablation System: Technical Feasibility and Safety in Treating 35 Hepatic Tumors
A. J. Weisbrod, T. D. Atwell, M. R. Callstrom, M. A. Farrell, J. N. Mandrekar, J. W. Charboneau;
Mayo Clinic, Rochester, MN.

P50 Microwave Ablation of Lung Malignancies: Safety and Efficacy in 50 Patients
F. J. Wolf, D. J. Grand, T. DiPetrillo, J. Machan, D. E. Dupuy;
Rhode Island Hospital Brown Medical School, Providence, RI.

P51 Percutaneous RFA of Liver and Lung Lesions in Colorectal Cancer Patients Who Have Received Avastin-based Chemotherapies
C. Wu, S. Shankar, A. Hassan, B. Piperdi;
UMass Memorial Medical Center, Worcester, MA.

P52 Immune Response after High Intensity Focused Ultrasound Ablation for H22 Tumor in Mice
P. Zhou1, M. Fu1, J. Bai2, Z. Wang2, F. Wu2;
1Chongqing First People's Hospital, Chongqing, CHINA, 2Chongqing Medical University, Chongqing, CHINA.

P53 The feasibility and efficiency of radiofrequency ablation in treating HCC patients with Child-Pugh C cirrhosis
W. Yang, M. Chen, S. Yin, W. Gao, H. Zhang, K. Yan;
The School of Oncology, Peking University, Beijing, CHINA.
Corporate Sponsors

Diamond Sponsors



Platinum Sponsors



Silver Sponsors



Bronze Sponsors

Philips Medical Systems



Co-Sponsors
Beverly Hills Sign  
 
© 2008 World Conference on Interventional Oncology. All Rights Reserved.